Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth

Aleksandra Fesiuk, Daniel Pölöske, Elvin D. de Araujo, Geordon A. Frere, Timothy B. Wright, Gary Tin, Yasir S. Raouf, Olasunkanmi O. Olaoye, Ji Sung Park, Nicolas Blavet, Boris Tichý, Michaela Schlederer, Sandra Högler, Michael Wolf, Cécile Philippe, Osman Aksoy, Adam Varady, Alejandro Medaglia Mata, Maxim Varenicja, Boglárka Szabó, Theresa Weiss, Gabriel Wasinger, Torben Redmer, Heidi A. Neubauer, Martin Susani, Clemens P. Spielvogel, Jing Ning, Maik Dahlhoff, Martin Schepelmann, Richard Kennedy, Richard Moriggl, Geoffrey Brown, Jenny Persson, Christopher Gerner, Vojtech Bystry, Oldamur Hollóczki, David M. Heery, Patrick T. Gunning, Olaf Merkel, Brigitte Hantusch#, Lukas Kenner

Open source

DOI: 10.1186/s12943-025-02451-2
Published: 2025-10-14
Container: Molecular Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-025-02451-2,
  title = {Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth},
  author = {Aleksandra Fesiuk and Daniel Pölöske and Elvin D. de Araujo and Geordon A. Frere and Timothy B. Wright and Gary Tin and Yasir S. Raouf and Olasunkanmi O. Olaoye and Ji Sung Park and Nicolas Blavet and Boris Tichý and Michaela Schlederer and Sandra Högler and Michael Wolf and Cécile Philippe and Osman Aksoy and Adam Varady and Alejandro Medaglia Mata and Maxim Varenicja and Boglárka Szabó and Theresa Weiss and Gabriel Wasinger and Torben Redmer and Heidi A. Neubauer and Martin Susani and Clemens P. Spielvogel and Jing Ning and Maik Dahlhoff and Martin Schepelmann and Richard Kennedy and Richard Moriggl and Geoffrey Brown and Jenny Persson and Christopher Gerner and Vojtech Bystry and Oldamur Hollóczki and David M. Heery and Patrick T. Gunning and Olaf Merkel and Brigitte Hantusch\# and Lukas Kenner},
  year = {2025},
  journal = {Molecular Cancer},
  doi = {10.1186/s12943-025-02451-2},
  url = {https://doi.org/10.1186/s12943-025-02451-2}
}

RIS

TY  - JOUR
TI  - Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
AU  - Aleksandra Fesiuk
AU  - Daniel Pölöske
AU  - Elvin D. de Araujo
AU  - Geordon A. Frere
AU  - Timothy B. Wright
AU  - Gary Tin
AU  - Yasir S. Raouf
AU  - Olasunkanmi O. Olaoye
AU  - Ji Sung Park
AU  - Nicolas Blavet
AU  - Boris Tichý
AU  - Michaela Schlederer
AU  - Sandra Högler
AU  - Michael Wolf
AU  - Cécile Philippe
AU  - Osman Aksoy
AU  - Adam Varady
AU  - Alejandro Medaglia Mata
AU  - Maxim Varenicja
AU  - Boglárka Szabó
AU  - Theresa Weiss
AU  - Gabriel Wasinger
AU  - Torben Redmer
AU  - Heidi A. Neubauer
AU  - Martin Susani
AU  - Clemens P. Spielvogel
AU  - Jing Ning
AU  - Maik Dahlhoff
AU  - Martin Schepelmann
AU  - Richard Kennedy
AU  - Richard Moriggl
AU  - Geoffrey Brown
AU  - Jenny Persson
AU  - Christopher Gerner
AU  - Vojtech Bystry
AU  - Oldamur Hollóczki
AU  - David M. Heery
AU  - Patrick T. Gunning
AU  - Olaf Merkel
AU  - Brigitte Hantusch#
AU  - Lukas Kenner
PY  - 2025
JO  - Molecular Cancer
DO  - 10.1186/s12943-025-02451-2
UR  - https://doi.org/10.1186/s12943-025-02451-2
ER  -

APA

Fesiuk, A., Pölöske, D., Araujo, E. D. D., Frere, G. A., Wright, T. B., Tin, G., Raouf, Y. S., Olaoye, O. O., Park, J. S., Blavet, N., Tichý, B., Schlederer, M., Högler, S., Wolf, M., Philippe, C., Aksoy, O., Varady, A., Mata, A. M., Varenicja, M., Szabó, B., Weiss, T., Wasinger, G., Redmer, T., Neubauer, H. A., Susani, M., Spielvogel, C. P., Ning, J., Dahlhoff, M., Schepelmann, M., Kennedy, R., Moriggl, R., Brown, G., Persson, J., Gerner, C., Bystry, V., Hollóczki, O., Heery, D. M., Gunning, P. T., Merkel, O., Hantusch#, B., & Kenner, L. (2025). Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth. Molecular Cancer. https://doi.org/10.1186/s12943-025-02451-2

Source records

crossref · retrieved 2026-09-26T17:35:02.737Z